Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Biotech Industry Analysis

UpdatedNov 18, 2025
DataAggregated Company Financials
Companies51
  • 7D-1.1%
  • 3M5.8%
  • 1Y-2.1%
  • YTD-9.2%

In the last week, the Biotech industry is up 2.3%, with BioArctic up 5.8%. Despite this gain, the industry's performance has been flat over the past year. As for the next few years, earnings are expected to grow by 37% per annum.

Industry Valuation and Performance

Has the Swedish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 19 Nov 2025SEK 206.2bSEK 37.4b-SEK 1,245,320,091.9338.5x-165.6x5.5x
Fri, 17 Oct 2025SEK 284.8bSEK 36.4bSEK 3.1b31.2x92x7.8x
Sun, 14 Sep 2025SEK 190.9bSEK 36.4bSEK 3.0b29.5x63.1x5.2x
Tue, 12 Aug 2025SEK 186.5bSEK 35.9bSEK 2.8b27.4x66.9x5.2x
Thu, 10 Jul 2025SEK 185.6bSEK 35.2bSEK 2.3b29.7x80.7x5.3x
Sat, 07 Jun 2025SEK 195.9bSEK 35.2bSEK 2.2b30.4x88.4x5.6x
Mon, 05 May 2025SEK 193.2bSEK 34.0bSEK 835.9m30.3x231.1x5.7x
Wed, 02 Apr 2025SEK 187.3bSEK 33.7bSEK 722.2m33x259.4x5.6x
Fri, 28 Feb 2025SEK 213.3bSEK 33.3bSEK 420.2m42.8x507.6x6.4x
Sun, 26 Jan 2025SEK 222.3bSEK 33.1b-SEK 4,401,238,938.02141.9x-50.5x6.7x
Tue, 24 Dec 2024SEK 215.8bSEK 33.0b-SEK 4,423,137,739.64157.1x-48.8x6.5x
Thu, 21 Nov 2024SEK 201.8bSEK 33.0b-SEK 4,538,431,652.35138.8x-44.5x6.1x
Sat, 19 Oct 2024SEK 214.8bSEK 31.4b-SEK 5,536,815,565.7551x-38.8x6.8x
Mon, 16 Sep 2024SEK 218.6bSEK 31.5b-SEK 5,518,169,191.2152.2x-39.6x6.9x
Wed, 14 Aug 2024SEK 194.7bSEK 31.4b-SEK 5,421,873,843.1744x-35.9x6.2x
Fri, 12 Jul 2024SEK 196.5bSEK 30.6b-SEK 5,534,756,552.1339.1x-35.5x6.4x
Sun, 09 Jun 2024SEK 196.5bSEK 30.6b-SEK 5,437,393,166.6639.3x-36.1x6.4x
Tue, 07 May 2024SEK 185.6bSEK 31.0b-SEK 5,452,321,619.2450.6x-34x6x
Thu, 04 Apr 2024SEK 181.4bSEK 29.8b-SEK 5,279,292,657.1160.1x-34.4x6.1x
Sat, 02 Mar 2024SEK 179.3bSEK 29.8b-SEK 5,620,184,219.8151.9x-31.9x6x
Mon, 29 Jan 2024SEK 187.0bSEK 28.7b-SEK 1,194,146,777.0060.8x-156.6x6.5x
Wed, 27 Dec 2023SEK 181.8bSEK 28.7b-SEK 1,195,865,403.0060.6x-152x6.3x
Fri, 24 Nov 2023SEK 173.4bSEK 28.7b-SEK 1,163,999,583.0056.1x-149x6.1x
Sun, 22 Oct 2023SEK 150.7bSEK 27.4b-SEK 1,984,284,666.0048.1x-75.9x5.5x
Tue, 19 Sep 2023SEK 150.9bSEK 27.4b-SEK 1,977,941,740.0050.8x-76.3x5.5x
Thu, 17 Aug 2023SEK 156.9bSEK 27.6b-SEK 1,574,843,040.0053.3x-99.6x5.7x
Sat, 15 Jul 2023SEK 153.9bSEK 26.5b-SEK 1,384,850,231.0046.2x-111.1x5.8x
Mon, 12 Jun 2023SEK 171.7bSEK 26.4b-SEK 1,234,687,020.0045.9x-139.1x6.5x
Wed, 10 May 2023SEK 179.6bSEK 26.4b-SEK 1,345,861,522.0046.4x-133.5x6.8x
Fri, 07 Apr 2023SEK 171.3bSEK 25.4b-SEK 2,051,129,033.0038.4x-83.5x6.7x
Sun, 05 Mar 2023SEK 173.6bSEK 25.4b-SEK 2,030,738,794.0040.2x-85.5x6.8x
Tue, 31 Jan 2023SEK 173.6bSEK 23.8b-SEK 1,871,268,457.0043.7x-92.7x7.3x
Thu, 29 Dec 2022SEK 153.9bSEK 23.8b-SEK 1,841,899,720.0031.3x-83.5x6.5x
Sat, 26 Nov 2022SEK 161.9bSEK 23.8b-SEK 1,770,055,192.0031.1x-91.5x6.8x
Price to Earnings Ratio

-91.5x


Total Market Cap: SEK 161.9bTotal Earnings: -SEK 1,770,055,192.00Total Revenue: SEK 23.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Biotech Industry Price to Earnings3Y Average -34.5x202320242025
Current Industry PE
  • Investors are pessimistic on the Swedish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 6.2x is higher than the industry's current PS ratio of 5.5x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Revenues for these companies have grown 16% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market-4.13%
Healthcare-2.56%
Biotech-1.09%
Biotech-1.09%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
BIOA B BioArcticSEK 280.205.8%
+SEK 1.3b		55.9%PE24.8x
VICO Vicore Pharma HoldingSEK 9.67-4.4%
SEK 348.1m		27.9%PS320.2x
HAMLET B Hamlet BioPharmaSEK 4.2014.3%
+SEK 93.3m		1.4%PS4191x
ONCO OncopeptidesSEK 5.104.4%
+SEK 58.7m		254.7%PS22.3x
CURAS CurasightDKK 5.2014.8%
+DKK 30.7m		-59.1%PB7.9x

Latest News

LIPUM
SEK 14.35
Lipum
7D
12.1%
1Y
-12.0%
SOBI
SEK 332.00
Swedish Orphan Biovitrum
7D
-1.3%
1Y
9.9%
BIOA B
SEK 280.20
BioArctic
7D
5.8%
1Y
55.9%

BioArctic AB (publ) (STO:BIOA B) Just Released Its Third-Quarter Earnings: Here's What Analysts Think

Nov 16
BioArctic AB (publ) (STO:BIOA B) Just Released Its Third-Quarter Earnings: Here's What Analysts Think
DMYD B
SEK 9.16
Diamyd Medical
7D
-8.4%
1Y
-25.8%
ALZ
SEK 1.44
Alzinova
7D
12.1%
1Y
-60.1%
VICO
SEK 9.67
Vicore Pharma Holding
7D
-4.4%
1Y
27.9%
HAMLET B
SEK 4.20
Hamlet BioPharma
7D
14.3%
1Y
1.4%
ONCO
SEK 5.10
Oncopeptides
7D
4.4%
1Y
254.7%
VITR
SEK 139.50
Vitrolife
7D
-2.1%
1Y
-36.3%

VITR: Stable Profitability And Marginal Rate Shift Will Drive Future Upside

Narrative Update on Vitrolife Analyst Price Target Vitrolife's analyst price target remains unchanged at SEK 193.50. Analysts cite only minor adjustments in growth and profitability forecasts, affirming their previous valuation stance.
BIOG B
SEK 100.80
BioGaia
7D
-1.7%
1Y
-2.3%
BONEX
SEK 199.10
Bonesupport Holding
7D
-4.1%
1Y
-40.6%

BONEX: Clinical Study Results Will Drive Long-Term Patient Outcome Improvements

Bonesupport Holding's analyst price target has been updated downward from SEK 401.80 to SEK 391.20, as analysts factor in slightly softer revenue growth forecasts and a higher discount rate. What's in the News Bonesupport announced positive results from a clinical study showing significantly improved patient-reported outcomes for CERAMENT G in single-stage revision surgery for periprosthetic joint infection of the hip (Key Developments).
SANION
SEK 16.28
Saniona
7D
0.5%
1Y
471.2%
FLUO
SEK 39.20
FluoGuide
7D
-14.8%
1Y
9.3%
CURAS
DKK 5.20
Curasight
7D
14.8%
1Y
-59.1%
BINV
SEK 28.95
BioInvent International
7D
-6.6%
1Y
-37.4%
EGTX
SEK 5.56
Egetis Therapeutics
7D
-10.0%
1Y
4.1%